FDA advises on drug naming; Novavax seeks new flu vax partner for Spain;

> New FDA guidance advises drugmakers on the creation of proprietary drug names to minimize medication errors. Guidance

> Novavax has discontinued its deal with ROVI Pharmaceuticals to develop the former's influenza vaccine for Spain. Release

> As the camera film business continues its decline, Kodak is using its manufacturing operations and expertise to produce gels for the pharma industry as well as inks and dyes for personal-care products. Article

> Regis Technologies of Morton Grove, IL, has passed the FDA's pre-approval inspection for its manufacture of the active ingredient in multiple sclerosis drug Ampyra, approved last month. Release

> Sweden's Medical Products Agency is proposing that an environmental certification for pharmaceutical production facilities be introduced into Good Manufacturing Practice requirements. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.